Entrectinib
Brand name: Rozlytrek
Entrectinib comes in 4 pill versions in our database, in 2 strengths, from 2 manufacturers. Check the imprint to tell them apart.
Entrectinib pill images
100 mg 2 pills
- ENT 100 Entrectinib 100 mg Yellow, capsule, 18 mm Used for lung cancer
- ENT 100 Entrectinib 100 mg Yellow, capsule Used for lung cancer
200 mg 2 pills
What is Entrectinib used for?
Entrectinib is used for lung cancer.
Official uses from the US prescribing label
ROS1-Positive Non-Small Cell Lung Cancer
ROZLYTREK is indicated for the treatment of adult patients with ROS1-positive metastatic non-small cell lung cancer (NSCLC), as detected by an FDA-approved test.
NTRK Gene Fusion-Positive Solid Tumors
ROZLYTREK is indicated for the treatment of adult and pediatric patients older than 1 month of age with solid tumors that:
- have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion, as detected by an FDA-approved test without a known acquired resistance mutation,
- are metastatic or where surgical resection is likely to result in severe morbidity, and
- have progressed following treatment or have no satisfactory alternative therapy.
This indication is approved under accelerated approval based on tumor response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trials.
From the FDA-approved label on DailyMed (published Dec 10, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.